dreamproit/uscode huggingface dataset:
42 U.S.C. § 247b–13a (THE PUBLIC HEALTH AND WELFARE)
§ 247b–13a. Screening and treatment for maternal depression
(a) Grants
The Secretary shall make grants to States to establish, improve, or maintain programs for screening, assessment, and treatment services, including culturally and linguistically appropriate services, as appropriate, for women who are pregnant, or who have given birth within the preceding 12 months, for maternal depression.
(b) Application
To seek a grant under this section, a State shall submit an application to the Secretary at such time, in such manner, and containing such information as the Secretary may require. At a minimum, any such application shall include explanations of—
(1) how a program, or programs, will increase the percentage of women screened and treated, as appropriate, for maternal depression in 1 or more communities; and
(2) how a program, or programs, if expanded, would increase access to screening and treatment services for maternal depression.
(c) Priority
In awarding grants under this section, the Secretary may give priority to States proposing to improve or enhance access to screening services for maternal depression in primary care settings.
(d) Use of funds
The activities eligible for funding through a grant under subsection (a)—
(1) shall include—
(A) providing appropriate training to health care providers; and
(B) providing information to health care providers, including information on maternal depression screening, treatment, and followup support services, and linkages to community-based resources; and
(2) may include—
(A) enabling health care providers (including obstetrician-gynecologists, pediatricians, psychiatrists, mental health care providers, and adult primary care clinicians) to provide or receive real-time psychiatric consultation (in-person or remotely) to aid in the treatment of pregnant and parenting women;
(B) establishing linkages with and among community-based resources, including mental health resources, primary care resources, and support groups; and
(C) utilizing telehealth services for rural areas and medically underserved areas (as defined in section 254c–14(a) of this title).
(e) Authorization of appropriations
To carry out this section, there are authorized to be appropriated $5,000,000 for each of fiscal years 2018 through 2022.
(July 1, 1944, ch. 373, title III, § 317L–1, as added Pub. L. 114–255, div. B, title X, § 10005, Dec. 13, 2016, 130 Stat. 1266.)
42 U.S.C. § 247d–5a (THE PUBLIC HEALTH AND WELFARE)
§ 247d–5a. Repealed. Pub. L. 114–255, div. A, title III, § 3044(b)(1), Dec. 13, 2016, 130 Stat. 1121
text: Section, Pub. L. 110–85, title XI, § 1111, Sept. 27, 2007, 121 Stat. 975, related to identification of clinically susceptible concentrations of antimicrobials. See section 360a–2 of Title 21, Food and Drugs.
42 U.S.C. § 280h–3 (THE PUBLIC HEALTH AND WELFARE)
§ 280h–3. Health professional education and training
(a) In general
The Secretary, acting through the Director of the Centers for Disease Control and Prevention, in collaboration with the Administrator of the Health Resources and Services Administration and the heads of other agencies, and in consultation with appropriate health professional associations, shall develop and carry out a program to educate and train health professionals in effective strategies to—
(1) better identify and assess patients with obesity or an eating disorder or patients at-risk of becoming obese or developing an eating disorder;
(2) counsel, refer, or treat patients with obesity or an eating disorder; and
(3) educate patients and their families about effective strategies to improve dietary habits and establish appropriate levels of physical activity.
(b) Authorization of appropriations
There are authorized to be appropriated to carry out this section such sums as may be necessary for each of the fiscal years 2001 through 2005.
(July 1, 1944, ch. 373, title III, § 399Z, as added Pub. L. 106–310, div. A, title XXIV, § 2401, Oct. 17, 2000, 114 Stat. 1160.)
heading: Education and Training on Eating Disorders
text: Pub. L. 114–255, div. B, title XIII, § 13006, Dec. 13, 2016, 130 Stat. 1287, provided that:
“The Secretary of Health and Human Services may facilitate the identification of model programs and materials for educating and training health professionals in effective strategies to—
“(1) identify individuals with eating disorders;
“(2) provide early intervention services for individuals with eating disorders;
“(3) refer patients with eating disorders for appropriate treatment;
“(4) prevent the development of eating disorders; and
“(5) provide appropriate treatment services for individuals with eating disorders.”
42 U.S.C. § 280i–4 (THE PUBLIC HEALTH AND WELFARE)
§ 280i–4. Authorization of appropriations
(a) Developmental disabilities surveillance and research program
To carry out section 280i of this title, there is authorized to be appropriated $22,000,000 for each of fiscal years 2015 through 2019.
(b) Autism education, early detection, and intervention
To carry out section 280i–1 of this title, there is authorized to be appropriated $48,000,000 for each of fiscal years 2015 through 2019.
(c) Interagency Autism Coordinating Committee; certain other programs
To carry out sections 280i–2 and 284g of this title, there is authorized to be appropriated $190,000,000 for each of fiscal years 2015 through 2019.
(July 1, 1944, ch. 373, title III, § 399EE, as added Pub. L. 109–416, § 4(a), Dec. 19, 2006, 120 Stat. 2829; amended Pub. L. 112–32, § 3, Sept. 30, 2011, 125 Stat. 361; Pub. L. 113–157, § 7, Aug. 8, 2014, 128 Stat. 1836; Pub. L. 114–255, div. A, title II, § 2042(f)(2), Dec. 13, 2016, 130 Stat. 1073.)
heading: Amendments
text: 2016—Subsec. (c). Pub. L. 114–255 substituted “280i–2” for “280i–2, 283j,”.
2014—Subsec. (a). Pub. L. 113–157, § 7(1), substituted “fiscal years 2015 through 2019” for “fiscal years 2012 through 2014”.
Subsec. (b). Pub. L. 113–157, § 7(2), substituted “fiscal years 2015 through 2019” for “fiscal years 2011 through 2014”.
Subsec. (c). Pub. L. 113–157, § 7(3), substituted “$190,000,000 for each of fiscal years 2015 through 2019” for “$161,000,000 for each of fiscal years 2011 through 2014”.
2011—Pub. L. 112–32 amended section generally. Prior to amendment, section authorized appropriations for fiscal years 2007 to 2011.
42 U.S.C. § 283a–1 (THE PUBLIC HEALTH AND WELFARE)
§ 283a–1. Annual reporting to prevent fraud and abuse
(a) Whistleblower complaints
(1) In general
On an annual basis, the Director of NIH shall submit to the Inspector General of the Department of Health and Human Services, the Secretary, the Committee on Energy and Commerce and the Committee on Appropriations of the House of Representatives, and the Committee on Health, Education, Labor, and Pensions and the Committee on Appropriations of the Senate a report summarizing the activities of the National Institutes of Health relating to whistleblower complaints.
(2) Contents
For each whistleblower complaint pending during the year for which a report is submitted under this subsection, the report shall identify the following:
(A) Each agency of the National Institutes of Health involved.
(B) The status of the complaint.
(C) The resolution of the complaint to date.
(b) First report
The first report under subsection (a) shall be submitted not later than 1 year after January 15, 2007.
(July 1, 1944, ch. 373, title IV, § 403B, as added Pub. L. 109–482, title I, § 104(a)(3), Jan. 15, 2007, 120 Stat. 3691; amended Pub. L. 114–255, div. A, title II, § 2042(b), Dec. 13, 2016, 130 Stat. 1073.)
heading: Amendments
text: 2016—Subsecs. (b), (c). Pub. L. 114–255 redesignated subsec. (c) as (b), substituted “subsection (a)” for “subsections (a) and (b)”, and struck out former subsec. (b), which related to annual report by the Director of NIH on experts and consultants whose services were obtained by the National Institutes of Health or its agencies.
heading: Effective Date
text: Section applicable only with respect to amounts appropriated for fiscal year 2007 or subsequent fiscal years, see section 109 of Pub. L. 109–482, set out as an Effective Date of 2007 Amendment note under section 281 of this title.
42 U.S.C. § 283a–2 (THE PUBLIC HEALTH AND WELFARE)
§ 283a–2. Annual reporting regarding training of graduate students for doctoral degrees
(a) In general
Each institution receiving an award under this subchapter for the training of graduate students for doctoral degrees shall annually report to the Director of NIH, with respect to graduate students supported by the National Institutes of Health at such institution—
(1) the percentage of such students admitted for study who successfully attain a doctoral degree; and
(2) for students described in paragraph (1), the average time between the beginning of graduate study and the receipt of a doctoral degree.
(3) 1 Provision of information to applicants
Each institution described in subsection (a) shall provide to each student submitting an application for a program of graduate study at such institution the information described in paragraphs (1) and (2) of such subsection with respect to the program or programs to which such student has applied.
(July 1, 1944, ch. 373, title IV, § 403C, as added Pub. L. 109–482, title I, § 104(a)(3), Jan. 15, 2007, 120 Stat. 3692; amended Pub. L. 110–85, title XI, § 1104(5), Sept. 27, 2007, 121 Stat. 975; Pub. L. 114–255, div. A, title II, § 2042(c), Dec. 13, 2016, 130 Stat. 1073.)
heading: Prior Provisions
text: A prior section 403C of act July 1, 1944, was renumbered section 403D and is classified to section 283a–3 of this title.
heading: Amendments
text: 2016—Subsec. (a)(2). Pub. L. 114–255 struck out “(not including any leaves of absence)” after “time”.
2007—Subsec. (a). Pub. L. 110–85, § 1104(5)(A), substituted “graduate students supported by the National Institutes of Health” for “each degree-granting program” in introductory provisions.
Subsec. (a)(1). Pub. L. 110–85, § 1104(5)(B), inserted “such” after “percentage of”.
Subsec. (a)(2). Pub. L. 110–85, § 1104(5)(C), inserted “(not including any leaves of absence)” after “average time”.
heading: Effective Date
text: Section applicable only with respect to amounts appropriated for fiscal year 2007 or subsequent fiscal years, see section 109 of Pub. L. 109–482, set out as an Effective Date of 2007 Amendment note under section 281 of this title.
42 U.S.C. § 283d (THE PUBLIC HEALTH AND WELFARE)
§ 283d. Children’s Vaccine Initiative
The Secretary, in consultation with the Director of the National Vaccine Program under subchapter XIX and acting through the Directors of the National Institute for Allergy and Infectious Diseases, the Eunice Kennedy Shriver National Institute of Child Health and Human Development, the National Institute for Aging, and other public and private programs, shall carry out activities, which shall be consistent with the global Children’s Vaccine Initiative, to develop affordable new and improved vaccines to be used in the United States and in the developing world that will increase the efficacy and efficiency of the prevention of infectious diseases. In carrying out such activities, the Secretary shall, to the extent practicable, develop and make available vaccines that require fewer contacts to deliver, that can be given early in life, that provide long lasting protection, that obviate refrigeration, needles and syringes, and that protect against a larger number of diseases.
(July 1, 1944, ch. 373, title IV, § 404B, as added Pub. L. 103–43, title II, § 204, June 10, 1993, 107 Stat. 146; amended Pub. L. 109–482, title I, § 103(b)(3), Jan. 15, 2007, 120 Stat. 3687; Pub. L. 110–154, § 1(b)(2), Dec. 21, 2007, 121 Stat. 1827; Pub. L. 114–255, div. A, title II, § 2042(d), Dec. 13, 2016, 130 Stat. 1073.)
heading: Amendments
text: 2016—Pub. L. 114–255 struck out subsec. (a) designation and heading “Development of New Vaccines” and subsec. (b). Prior to amendment, text of subsec. (b) read as follows: “In the report required in section 300aa–4 of this title, the Secretary, acting through the Director of the National Vaccine Program under subchapter XIX, shall include information with respect to activities and the progress made in implementing the provisions of this section and achieving its goals.”
2007—Subsec. (a). Pub. L. 110–154 substituted “Eunice Kennedy Shriver National Institute of Child Health and Human Development” for “National Institute for Child Health and Human Development”.
Subsec. (c). Pub. L. 109–482 struck out heading and text of subsec. (c). Text read as follows: “In addition to any other amounts authorized to be appropriated for activities of the type described in this section, there are authorized to be appropriated to carry out this section $20,000,000 for fiscal year 1994, and such sums as may be necessary for each of the fiscal years 1995 and 1996.”
heading: Effective Date of 2007 Amendment
text: Amendment by Pub. L. 109–482 applicable only with respect to amounts appropriated for fiscal year 2007 or subsequent fiscal years, see section 109 of Pub. L. 109–482, set out as a note under section 281 of this title.
42 U.S.C. § 283j (THE PUBLIC HEALTH AND WELFARE)
§ 283j. Repealed. Pub. L. 114–255, div. A, title II, § 2042(f)(1), Dec. 13, 2016, 130 Stat. 1073
text: Section, July 1, 1944, ch. 373, title IV, § 404H, as added Pub. L. 109–416, § 2(b), Dec. 19, 2006, 120 Stat. 2821, required review and report on centers of excellence funded under this subchapter.
42 U.S.C. § 283o (THE PUBLIC HEALTH AND WELFARE)
§ 283o. Next generation of researchers
(a) Next generation of researchers initiative
There shall be established within the Office of the Director of the National Institutes of Health, the Next Generation of Researchers Initiative (referred to in this section as the “Initiative”), through which the Director shall coordinate all policies and programs within the National Institutes of Health that are focused on promoting and providing opportunities for new researchers and earlier research independence.
(b) Activities
The Director of the National Institutes of Health, through the Initiative shall—
(1) promote policies and programs within the National Institutes of Health that are focused on improving opportunities for new researchers and promoting earlier research independence, including existing policies and programs, as appropriate;
(2) develop, modify, or prioritize policies, as needed, within the National Institutes of Health to promote opportunities for new researchers and earlier research independence, such as policies to increase opportunities for new researchers to receive funding, enhance training and mentorship programs for researchers, and enhance workforce diversity;
(3) coordinate, as appropriate, with relevant agencies, professional and academic associations, academic institutions, and others, to improve and update existing information on the biomedical research workforce in order to inform programs related to the training, recruitment, and retention of biomedical researchers; and
(4) carry out other activities, including evaluation and oversight of existing programs, as appropriate, to promote the development of the next generation of researchers and earlier research independence.
(July 1, 1944, ch. 373, title IV, § 404M, as added Pub. L. 114–255, div. A, title II, § 2021(a), Dec. 13, 2016, 130 Stat. 1051.)
42 U.S.C. § 283p (THE PUBLIC HEALTH AND WELFARE)
§ 283p. Population focused research
The Director of the National Institutes of Health shall, as appropriate, encourage efforts to improve research related to the health of sexual and gender minority populations, including by—
(1) facilitating increased participation of sexual and gender minority populations in clinical research supported by the National Institutes of Health, and reporting on such participation, as applicable;
(2) facilitating the development of valid and reliable methods for research relevant to sexual and gender minority populations; and
(3) addressing methodological challenges.
(July 1, 1944, ch. 373, title IV, § 404N, as added Pub. L. 114–255, div. A, title II, § 2038(d), Dec. 13, 2016, 130 Stat. 1065.)
heading: Reporting
text: Pub. L. 114–255, div. A, title II, § 2038(e), Dec. 13, 2016, 130 Stat. 1065, provided that:
“(1) In general.—
The Secretary, in collaboration with the Director of the National Institutes of Health, shall as appropriate—
“(A) continue to support research for the development of appropriate measures related to reporting health information about sexual and gender minority populations; and
“(B) not later than 2 years after the date of enactment of this Act [Dec. 13, 2016], disseminate and make public such measures.
“(2) National academy of medicine recommendations.—
In developing the measures described in paragraph (1)(A), the Secretary shall take into account recommendations made by the National Academy of Medicine.”
42 U.S.C. § 283q (THE PUBLIC HEALTH AND WELFARE)
§ 283q. Eureka prize competitions
(a) In general
Pursuant to the authorities and processes established under section 3719 of title 15, the Director of the National Institutes of Health shall support prize competitions for one or both of the following goals:
(1) Identifying and funding areas of biomedical science that could realize significant advancements through a prize competition.
(2) Improving health outcomes, particularly with respect to human diseases and conditions—
(A) for which public and private investment in research is disproportionately small relative to Federal Government expenditures on prevention and treatment activities with respect to such diseases and conditions, such that Federal expenditures on health programs would be reduced;
(B) that are serious and represent a significant disease burden in the United States; or
(C) for which there is potential for significant return on investment to the United States.
(b) Tracking; reporting
The Director of the National Institutes of Health shall—
(1) collect information on—
(A) the effect of innovations funded through the prize competitions under this section in advancing biomedical science or improving health outcomes pursuant to subsection (a); and
(B) the effect of the innovations on Federal expenditures; and
(2) include the information collected under paragraph (1) in the triennial report under section 283 of this title (as amended by section 2032).
(Pub. L. 114–255, div. A, title II, § 2002, Dec. 13, 2016, 130 Stat. 1047.)
heading: References in Text
text: Section 2032, referred to in subsec. (b)(2), means section 2032 of Pub. L. 114–255.
heading: Codification
text: Section was enacted as part of the 21st Century Cures Act, and not as part of the Public Health Service Act which comprises this chapter.
42 U.S.C. § 284r (THE PUBLIC HEALTH AND WELFARE)
§ 284r. Basic research
(1) Developing policies
Not later than 2 years after December 13, 2016, the Director of the National Institutes of Health (referred to in this section as the “Director of the National Institutes of Health”), taking into consideration the recommendations developed under section 2039,1 shall develop policies for projects of basic research funded by National Institutes of Health to assess—
(A) relevant biological variables including sex, as appropriate; and
(B) how differences between male and female cells, tissues, or animals may be examined and analyzed.
(2) Revising policies
The Director of the National Institutes of Health may update or revise the policies developed under paragraph (1) as appropriate.
(3) Consultation and outreach
In developing, updating, or revising the policies under this section, the Director of the National Institutes of Health shall—
(A) consult with—
(i) the Office of Research on Women’s Health;
(ii) the Office of Laboratory Animal Welfare; and
(iii) appropriate members of the scientific and academic communities; and
(B) conduct outreach to solicit feedback from members of the scientific and academic communities on the influence of sex as a variable in basic research, including feedback on when it is appropriate for projects of basic research involving cells, tissues, or animals to include both male and female cells, tissues, or animals.
(4) Additional requirements
The Director of the National Institutes of Health shall—
(A) ensure that projects of basic research funded by the National Institutes of Health are conducted in accordance with the policies developed, updated, or revised under this section, as applicable; and
(B) encourage that the results of such research, when published or reported, be disaggregated as appropriate with respect to the analysis of any sex differences.
(Pub. L. 114–255, div. A, title II, § 2038(g), Dec. 13, 2016, 130 Stat. 1066.)
heading: References in Text
text: Section 2039, referred to in par. (1), is section 2039 of Pub. L. 114–255, set out as a note under section 282 of this title.
heading: Codification
text: Section was enacted as part of the 21st Century Cures Act, and not as part of the Public Health Service Act which comprises this chapter.
42 U.S.C. § 285q–3 (THE PUBLIC HEALTH AND WELFARE)
§ 285q–3. Repealed. Pub. L. 114–255, div. A, title II, § 2042(h)(1), Dec. 13, 2016, 130 Stat. 1073
text: Section, July 1, 1944, ch. 373, title IV, § 464Y, formerly § 486, as added Pub. L. 99–158, § 2, Nov. 20, 1985, 99 Stat. 869; renumbered § 485A, renumbered § 464Y, and amended Pub. L. 103–43, title I, § 141(a)(1), title XV, § 1511(a)(4), (b)(2), (4)(C), June 10, 1993, 107 Stat. 136, 179, related to biennial report of activities of the National Institute of Nursing Research.
42 U.S.C. § 285t–2 (THE PUBLIC HEALTH AND WELFARE)
§ 285t–2. Repealed. Pub. L. 114–255, div. A, title II, § 2022(c)(1), Dec. 13, 2016, 130 Stat. 1054
text: Section, July 1, 1944, ch. 373, title IV, § 464z–5, formerly § 485G, as added Pub. L. 106–525, title I, § 103, Nov. 22, 2000, 114 Stat. 2503; amended Pub. L. 109–482, title I, § 103(b)(46), Jan. 15, 2007, 120 Stat. 3688; renumbered § 464z–5 and amended Pub. L. 111–148, title X, § 10334(c)(1)(D)(i), (iii), Mar. 23, 2010, 124 Stat. 973, related to loan repayment program for minority health disparities research.
42 U.S.C. § 287c (THE PUBLIC HEALTH AND WELFARE)
§ 287c. Transferred
heading: Codification
text: Section, act July 1, 1944, ch. 373, title IV, § 485B, as added Pub. L. 103–43, title XV, § 1521(2), June 10, 1993, 107 Stat. 180, which set out the purpose of the National Center for Human Genome Research, was renumbered section 464z–1 of act July 1, 1944, by Pub. L. 109–482, title I, § 101(c)(4)(A), Jan. 15, 2007, 120 Stat. 3681, and transferred to section 285s of this title.
heading: Prior Provisions
text: Another prior section 287c, act July 1, 1944, ch. 373, title IV, § 483, as added Nov. 20, 1985, Pub. L. 99–158, § 2, 99 Stat. 867, and amended, which related to purpose of National Center for Nursing Research, was renumbered section 464V of act July 1, 1944, by Pub. L. 103–43, title XV, § 1511(b)(2), June 10, 1993, 107 Stat. 179, and transferred to section 285q of this title.
A prior section 287c–1, act July 1, 1944, ch. 373, title IV, § 484, as added Nov. 20, 1985, Pub. L. 99–158, § 2, 99 Stat. 867, and amended, which related to specific authorities of the Director of the Center, was renumbered section 464W of act July 1, 1944, by Pub. L. 103–43, title XV, § 1511(b)(2), June 10, 1993, 107 Stat. 179, and transferred to section 285q–1 of this title.
A prior section 287c–2, act July 1, 1944, ch. 373, title IV, § 485, as added Nov. 20, 1985, Pub. L. 99–158, § 2, 99 Stat. 867, and amended, which related to the advisory council for the Center, was renumbered section 464X of act July 1, 1944, by Pub. L. 103–43, title XV, § 1511(b)(2), June 10, 1993, 107 Stat. 179, and transferred to section 285q–2 of this title.
A prior section 287c–3, act July 1, 1944, ch. 373, title IV, § 486, as added Nov. 20, 1985, Pub. L. 99–158, § 2, 99 Stat. 869, and amended, which related to biennial report of activities of the Center, was renumbered section 464Y of act July 1, 1944, by Pub. L. 103–43, title XV, § 1511(b)(2), June 10, 1993, 107 Stat. 179, and transferred to section 285q–3 of this title. Section 285q–3 was subsequently repealed by Pub. L. 114–255, div. A, title II, § 2042(h)(1), Dec. 13, 2016, 130 Stat. 1073.